GSK Committed To Patient Outcomes
Dr. Jonathan Pan, Vice President, GM of Malaysia, GSK
30-May-22 08:00
Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
GSK will split into two new companies in 2022, they are GSK and Haleon. So what does this spin-off mean for Malaysia and the healthcare industry? Philip See speaks to Dr. Jonathan Pan, Vice President and GM of Malaysia and Brunei at GSK about their top-selling drugs, their role in the Covid-19 pandemic, and can Malaysia be a vaccine manufacturing hub?
Produced by: Moh Heng Ying
Presented by: Philip See
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: Corporates, managing disease, medical advances
Tags: gsk,
